Equities

Creightons PLC

CRL:LSE

Creightons PLC

Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (GBX)25.00
  • Today's Change0.00 / 0.00%
  • Shares traded2.00k
  • 1 Year change-29.58%
  • Beta0.8248
Data delayed at least 20 minutes, as of Apr 25 2024 08:00 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Creightons PLC's revenues fell -4.24% from 61.16m to 58.57m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 3.11m to 514.00k, a -83.47% decrease.
Gross margin42.50%
Net profit margin2.10%
Operating margin3.18%
Return on assets2.51%
Return on equity4.69%
Return on investment3.64%
More ▼

Cash flow in GBPView more

In 2023, Creightons PLC increased its cash reserves by 96.79%, or 813.00k. The company earned 5.81m from its operations for a Cash Flow Margin of 9.92%. In addition the company used 2.64m on investing activities and also paid 2.35m in financing cash flows.
Cash flow per share0.0341
Price/Cash flow per share6.08
Book value per share0.3787
Tangible book value per share0.1773
More ▼

Balance sheet in GBPView more

Creightons PLC has a Debt to Total Capital ratio of 21.78%, a higher figure than the previous year's 19.26%.
Current ratio1.95
Quick ratio1.12
Total debt/total equity0.2784
Total debt/total capital0.2178
More ▼

Growth rates in GBP

Year on year, growth in earnings per share excluding extraordinary items dropped -83.61%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
Div yield(5 year avg)0.84%
Div growth rate (5 year)--
Payout ratio (TTM)0.00%
EPS growth(5 years)-18.83
EPS (TTM) vs
TTM 1 year ago		63.62
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.